Atlas Trials

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Clinical trial NCT03331211 · UNKNOWN

Trial details

NCT number
NCT03331211
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Leukemia, Lymphoblastic, Acute
Start date
2017-11-01
Primary completion
2019-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.